Skip to search formSkip to main contentSkip to account menu

incobotulinumtoxinA

Known as: BoNT-A 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (3)

Botulinum Toxin Type ANeuromuscular AgentsNeurotoxins
INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

Narrower (3)

NT 201Xeominbocouture

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
Background We evaluated quality of life among subjects with upper- and lower-limb spasticity who received escalating doses of… 
2020
2020
IncobotulinumtoxinA Treatment in Upper‐Limb Poststroke Spasticity in the Open‐Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life
Poststroke spasticity affects motor function and the ability to perform activities of daily living, with the potential to affect… 
2019
2019
Botulinum neurotoxin serotype D – A potential treatment alternative for BoNT/A and B non-responding patients
2017
2017
Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.
BACKGROUND: IncobotulinumtoxinA is a botulinum neurotoxin type A that is free from complexing proteins and is used in various… 
2017
2017
Efficacy and Tolerability of IncobotulinumtoxinA for Treating Glabellar Frown Lines in Korean Adults: A Postmarketing Observational Study
BACKGROUND IncobotulinumtoxinA is safe and effective in Caucasian adults. Its effects have been less documented in Asian adults… 
Review
2016
Review
2016
IncobotulinumtoxinA: A Review in Upper Limb Spasticity
Intramuscular incobotulinumtoxinA (Xeomin®) is indicated for the treatment or improvement of adult patients with upper limb… 
Review
2015
Review
2015
Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
Background IncobotulinumtoxinA (Xeomin®) is a purified botulinum neurotoxin type A formulation, free from complexing proteins… 
2015
2015
IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study
Purpose To characterize utilization patterns and treatment satisfaction with incobotulinumtoxinA for aesthetic indications and… 
Review
2012
Review
2012
Relative potency of incobotulinumtoxinA vs onabotulinumtoxinA a meta-analysis of key evidence.
Botulinum neurotoxin-A (BoNT-A) has become widely used in aesthetic applications over the past 20 years with several formulations… 
2010
2010
Characterization of SNARE Cleavage Products Generated by Formulated Botulinum Neurotoxin Type-A Drug Products
The study evaluated substrate cleavage product(s) generated by three botulinum neurotoxin serotype A (BoNT/A) medicinal drug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)